Institutional Ownership Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). We have compiled data on the 523 institutions that hold shares in the stock, with a total of 58 Million shares, which have been reported (via 13F filing form) to have a value of $2.89 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Aug 14, 2024 Q2 2024 |
4
shares
|
$198
0.0% of portfolio
|
Q3 2023
New holding
|
|
Assetmark, Inc
|
Aug 13, 2024 Q2 2024 |
4
shares
|
$198
0.0% of portfolio
|
Q2 2024
Reduced 63.64%
|
|
Baldwin Brothers LLC
|
Jul 12, 2024 Q2 2024 |
4
shares
|
$198
0.0% of portfolio
|
Q2 2024
New holding
|
|
Mv Capital Management, Inc.
|
Aug 01, 2024 Q2 2024 |
3
shares
|
$148
0.0% of portfolio
|
Q2 2024
New holding
|
|
Robbins Farley LLC
Manchester, NH |
Jul 16, 2024 Q2 2024 |
3
shares
|
$148
0.0% of portfolio
|
Q3 2023
New holding
|
|
Jnba Financial Advisors
|
Jul 22, 2024 Q2 2024 |
2
shares
|
$99
0.0% of portfolio
|
Q2 2024
New holding
|
|
Frazier Financial Advisors, LLC
Columbus, OH |
Aug 12, 2024 Q2 2024 |
2
shares
|
$99
0.0% of portfolio
|
Q1 2024
New holding
|
|
Planning Capital Management Corp
Paoli, PA |
Aug 12, 2024 Q2 2024 |
1
shares
|
$49
0.0% of portfolio
|
Q2 2024
New holding
|
|
Hallmark Capital Management Inc
|
Aug 08, 2024 Q2 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|